NYSE Composite ended the session with Novartis jumping 3.02% to $91.22 on Monday, after two successive sessions in a row of gains. NYSE Composite rose 0.23% to $14,416.29, following last session’s downward trend on what was a somewhat positive trend exchanging session today.
Novartis today’s close was $91.22, 9.45% under its 52-week high of $99.84.
Novartis’s sales growth is 3.9% for the current quarter and 6.3% for the next. The company’s growth estimates for the present quarter and the next is 2.3% and 1.3%, respectively.
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 49.58B for the twelve trailing months.
Novartis’s last day, last week, and last month’s average volatility was a positive 0.19%, a negative 0.77%, and a positive 0.01%, respectively.
Novartis’s last day, last week, and last month’s high and low average amplitude percentage was 0.46%, 0.98%, and 1.05%, respectively.
Novartis’s Stock Yearly Top and Bottom Value
Novartis’s stock is valued at $91.22 at 16:27 EST, under its 52-week high of $99.84 and way above its 52-week low of $69.18.
Novartis’s Moving Average
Novartis’s value is higher than its 50-day moving average of $88.95 and higher than its 200-day moving average of $86.93.